TY - JOUR
T1 - Neuronal network dysfunction in a model for Kleefstra syndrome mediated by enhanced NMDAR signaling
AU - Frega, Monica
AU - Linda, Katrin
AU - Keller, Jason M.
AU - Gümüş-Akay, Güvem
AU - Mossink, Britt
AU - van Rhijn, Jon Ruben
AU - Negwer, Moritz
AU - Klein Gunnewiek, Teun
AU - Foreman, Katharina
AU - Kompier, Nine
AU - Schoenmaker, Chantal
AU - van den Akker, Willem
AU - van der Werf, Ilse
AU - Oudakker, Astrid
AU - Zhou, Huiqing
AU - Kleefstra, Tjitske
AU - Schubert, Dirk
AU - van Bokhoven, Hans
AU - Nadif Kasri, Nael
PY - 2019/10/30
Y1 - 2019/10/30
N2 - Kleefstra syndrome (KS) is a neurodevelopmental disorder caused by mutations in the histone methyltransferase EHMT1. To study the impact of decreased EHMT1 function in human cells, we generated excitatory cortical neurons from induced pluripotent stem (iPS) cells derived from KS patients. Neuronal networks of patient-derived cells exhibit network bursting with a reduced rate, longer duration, and increased temporal irregularity compared to control networks. We show that these changes are mediated by upregulation of NMDA receptor (NMDAR) subunit 1 correlating with reduced deposition of the repressive H3K9me2 mark, the catalytic product of EHMT1, at the GRIN1 promoter. In mice EHMT1 deficiency leads to similar neuronal network impairments with increased NMDAR function. Finally, we rescue the KS patient-derived neuronal network phenotypes by pharmacological inhibition of NMDARs. Summarized, we demonstrate a direct link between EHMT1 deficiency and NMDAR hyperfunction in human neurons, providing a potential basis for more targeted therapeutic approaches for KS.
AB - Kleefstra syndrome (KS) is a neurodevelopmental disorder caused by mutations in the histone methyltransferase EHMT1. To study the impact of decreased EHMT1 function in human cells, we generated excitatory cortical neurons from induced pluripotent stem (iPS) cells derived from KS patients. Neuronal networks of patient-derived cells exhibit network bursting with a reduced rate, longer duration, and increased temporal irregularity compared to control networks. We show that these changes are mediated by upregulation of NMDA receptor (NMDAR) subunit 1 correlating with reduced deposition of the repressive H3K9me2 mark, the catalytic product of EHMT1, at the GRIN1 promoter. In mice EHMT1 deficiency leads to similar neuronal network impairments with increased NMDAR function. Finally, we rescue the KS patient-derived neuronal network phenotypes by pharmacological inhibition of NMDARs. Summarized, we demonstrate a direct link between EHMT1 deficiency and NMDAR hyperfunction in human neurons, providing a potential basis for more targeted therapeutic approaches for KS.
U2 - 10.1038/s41467-019-12947-3
DO - 10.1038/s41467-019-12947-3
M3 - Article
C2 - 31666522
AN - SCOPUS:85074276966
SN - 2041-1723
VL - 10
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 4928
ER -